NeuroOne Medical Technologies Corporation (NMTC) financial statements and ratios from SEC XBRL: revenue $9.10M (TTM), net margin -39.6%, revenue growth 16.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $9.10M |
| Net Margin | -39.6% |
| Revenue Growth (YoY) | 16.3% |
| EPS Growth (YoY) | 666.7% |
| FCF Growth (YoY) | 306.8% |
| Price / Book | 5.20 |
| Price / Sales | 2.28 |
| FCF Yield | -91.1% |
| Altman Z-Score | 7.75 (safe) |
| Sector P/E (Healthcare) | 21.6 |
NMTC overview · NMTC earnings · NMTC KPIs · NMTC investor relations · NMTC ownership · NMTC peers · NMTC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.